Can Bill Gruber Take Solace Where He Took Interlace?
Medtech Talk - A podcast by Healthegy

Categories:
Solace Therapeutics CEO Bill Gruber hopes to repeat the successful exit he helped execute when Hologic paid close to $300 million for his previous company Interlace.